Publication: Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines
| dc.contributor.author | Andric Petrovic, Sanja (55488423700) | |
| dc.contributor.author | Jankovic, Dusan (59312906700) | |
| dc.contributor.author | Kaurin, Nina (58549928900) | |
| dc.contributor.author | Mandic Maravic, Vanja (56663255900) | |
| dc.contributor.author | Pesic, Danilo (55582296200) | |
| dc.contributor.author | Ristic, Ivan (57191339222) | |
| dc.contributor.author | Maric, Nadja P. (57226219191) | |
| dc.date.accessioned | 2025-06-12T11:50:12Z | |
| dc.date.available | 2025-06-12T11:50:12Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Objective: Bipolar disorders (BD) are characterized by highly recurrent nature, necessitating adequate maintenance treatment for long-term disorder control. This study aimed to investigate real-world prescribing patterns among outpatients with BD, focusing on the utilisation of antidepressants (AD) and benzodiazepines (BDZ). Methods: We analysed prescription patterns of the five main groups of psychotropic medications (antipsychotics, mood stabilizers, AD, BDZ, and anticholinergic medications) and their relationships with basic socio-demographic and clinical data in a sample of 107 clinically stable BD outpatients (75.7% female, age 44.8 ± 11.7). Results: Maintenance therapy predominantly involved polypharmacy (92.5%), with mood stabilizers (87.9%) and antipsychotics (80.4%, predominantly second-generation) being the most commonly prescribed. Our findings highlight a high percentage of patients prescribed AD (50.5%) and BDZ (54.2%). BDZ patients, compared to the non-BDZ group in maintenance treatment, were significantly older with longer psychiatric history and a decreased likelihood of comorbid personality disorder diagnoses. Conclusions: This study offers insights into prescribing practices within a university psychiatric clinic in the Western Balkans. The prevalent use of polypharmacy in real-world clinical settings, along with high percentage of patients prescribed AD and BDZ, suggests a gap between guideline recommendations and clinical practice, indicating a lack of consensus or standardized approaches in clinical practice. © 2024 Informa UK Limited, trading as Taylor & Francis Group. | |
| dc.identifier.uri | https://doi.org/10.1080/13651501.2024.2398796 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203066953&doi=10.1080%2f13651501.2024.2398796&partnerID=40&md5=0550cfa6b40768bd4c15ea218b0b19e6 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/1436 | |
| dc.subject | antidepressants | |
| dc.subject | benzodiazepines | |
| dc.subject | Bipolar disorders | |
| dc.subject | maintenance treatment | |
| dc.subject | prescribing guidelines | |
| dc.title | Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines | |
| dspace.entity.type | Publication |
